Monthly Archives: July 2016

Canadian Government Invests in Elcora’s Graphene Research and Development Centre

HALIFAX, NS / ACCESSWIRE / July 21, 2016 / Troy Grant, President and CEO of ELCORA ADVANCED MATERIALS CORP. (TSXV: ERA) (OTCQB: ECORF) (FSE: ELM), (the “Company” or “Elcora”), is pleased to announce that yesterday, July 20, 2016, Darrell Samson, Member of Parliament for Sackville-Preston-Chezzetcook, was in Bedford touring Elcora’s new Graphene Research and Development (R&D) Centre. During his visit, MP Samson announced a $495,750 repayable contribution to the project through ACOA’s Business Development Program (BDP). This support has assisted Elcora with purchasing equipment and completing renovations to its new R&D Centre, which is now up and running at full capacity. Funds are also being allocated to hire staff and conduct marketing activities.

Elcora will use its new R&D Centre to explore further applications of the raw material graphite, which is processed into graphene. Initially, the company is planning for small scale production of up to 100 kg of graphene per year. Current forecasts are to increase output to 10 tons per year within a few years. An integral component of Elcora’s research and marketing will be working with application developers to use graphene in the commercialization of products.

The potential uses for graphene are virtually limitless, from bullet proof vests to water purification. Elcora is dedicated to electricity storage, specifically developing batteries for electric cars. That’s why, on Wednesday, June 22, Elcora hosted the first North America stop of the 80eDays Electric Car Challenge. Eleven international race teams met at the new Graphene R&D Centre to be briefed on the route. This event helped to demonstrate that electric cars are a sustainable, reliable means of transportation. Elcora’s scientists are dedicated to unlocking the full potential of graphene. They are creating a strong foundation of research to support new opportunities and discoveries that will help make Nova Scotia an international centre of interest for the development of graphene applications.

The Government of Canada and the governments of the four Atlantic Provinces are committed to working together to build a vibrant economic future for Atlantic Canada. Through the Atlantic Growth Strategy, they are focusing efforts and resources to stimulate the region’s economy and address both long standing and emerging regional challenges, and build on Atlantic Canada’s competitive advantages, such as its strong export potential, growing innovation ecosystem, and skilled workforce.

Quotes

“The Government of Canada is making targeted investments to expand innovative research in Clean Technology. Organizations such as Elcora will help to drive economic growth and build on the strong foundation of scientific research in the region.”

The Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for the Atlantic Canada Opportunities Agency

“Supporting clean technology projects such as this one will help to diversify our region’s economy, open up new markets and create high-quality jobs for Atlantic Canadians. Exploring new applications of revolutionary materials like graphene will help to accelerate clean growth, and it will all be done right here in Bedford, Nova Scotia.”

– Darrell Samson, Member of Parliament for Sackville-Preston-Chezzetcook

“Graphene is widely believed to be the next wonder substance that will have the ability to change mankind. The race is on to refine processing technology and to discover practical applications for this material. While the challenge is enormous, the rewards to be had by advancing this material commercially are even greater. This lab is at the forefront in that development and could not have happened without the support of these targeted investments by our elected officials.”

Troy Grant, President, Elcora Advanced Materials Corporation

Associated Links

About Elcora Advanced Materials

Elcora was founded in 2011 and has been structured to become a vertically integrated graphite & graphene company that mines, processes, refines graphite, and produces both the graphene and end user graphene applications.  As part of the vertical integration strategy, Elcora has secured high-grade graphite and graphene precursor graphite from its interest in the operation of the Ragedara mine in Sri Lanka which is already in production. Elcora has developed a unique low cost effective processes to make high quality graphite and graphene that are commercially scalable. This combination means that Elcora has the tools and resources for graphite and graphene vertical integration.

Graphene is the basic building block of graphite, which is made of stacks of graphene layers. Graphene is made of a single layer of carbon atoms that are bonded together in a repeating pattern of hexagons. The one atom thick graphene is one million times thinner than paper, so thin that it is considered two-dimensional.

Graphene’s flat honeycomb pattern grants it many unusual characteristics. Graphene is stronger than diamond, about 100 times stronger than the strongest steel with equivalent thickness, with a tensile stiffness of 150,000,000 psi, and is the thinnest and strongest known material. This gives graphene many competing advantages in that it can be used as a textile to make wearable electronics or bulletproof vests. Graphene is an excellent conductor of heat and electricity like silicon; however, unlike silicon, graphene is highly flexible and conducts electricity much more efficiently. Since it is such a versatile material, the applications for graphene are limitless. Some examples of graphene applications are: ocean water purification systems, medical devices such as implants or pacemakers, construction materials, or coatings.

For further information please visit the company’s website at http://www.elcoracorp.com.

For further information please contact: Troy Grant, Director, President and CEO, Elcora Resources Corp., T: 902 802-8847 F: 902 446-2001.

CAUTIONARY STATEMENT:

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release. No stock Exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. This News Release includes certain “forward-looking statements”. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding potential mineralization and reserves, exploration results, and future plans and objectives of Elcora, are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Elcora’s expectations are exploration risks detailed herein and from time to time in the filings made by Elcora with securities regulators.

Investors are cautioned that, except as disclosed in the filing statement prepared in connection with the transaction, any information released or received with respect to the transaction may not be accurate or complete and should not be relied upon.

SOURCE: Elcora Advanced Materials Corporation.

ReleaseID: 442665

Thermalabs Brand Reviewing Its Global Market Strategy

Thermalabs is reviewing its global prospecting approaches.

Thermalabs Brand Reviewing Its Global Market Strategy

New York, United States – July 21, 2016 /MarketersMedia/

Cosmetics firm Thermalabs has said that it’s currently reviewing its global marketing efforts. This is an interesting move for thousands of Thermalabs retailers around the world. Apparently, the company is looking to boost its online revenue while also counting on local distribution channels. It’s no secret that most of Thermalabs customers are online shoppers. However, the firm is looking to utilize the small section that still prefers to get their products from local cosmetic outlets.

Thermalabs is a major cosmetics firm based in the United States. The company opened its doors some three years ago, starting out with a tanning lotion known as ‘the natural self-tanner’. This was an exclusive formulation that featured unique ingredients such as Aloe Vera and Japanese Green Tea. Thermalabs focus on natural and organic ingredients at a time when most people are concerned about the safety of cosmetics products made this lotion a major hit, selling thousands of units within its first week in the market. Thermalabs pre-launch campaign, as well as the company’s ability to highlight the product’s unique benefits over the competition, helped make the natural self tanner the success it turned out to be.

Thermalabs is dedicated to a cancer-free world. At a time when millions of people are diagnosed with skin cancer each year, the firm is determined to create quality products that deliver the expected results within the confines of health. The firm contributes a tenth of its annual profits to charity, mostly to skincare organizations that create awareness on cancer, as well as educational outfits that are researching to find a cure for cancer and other common skin ailments.

In recent times, Thermalabs has created multiple sub-brands as a way to expand its influence beyond the self tanning niche, where it has made a name for itself. Thermalabs self tanners and tanning accessories are industry-leading products, highly reviewed by critics and trusted by millions of customers worldwide.

Last year, Thermalabs introduced Supremasea. This is a new sub-brand that will be tasked with prospecting the company’s private collection of skincare products created using salts from the Dead Sea. Already, Supremasea’s first product is a major performer in the market. Known as Tan Enhancer, the product is a luxury lotion that moisturizes and protects the skin. Another sub-brand that the company has established in recent past is Tent World. This will be tasked with prospecting the firm’s upcoming range of beach and sports tents. Mercury Beach Tent, the first product to be marketed by Tent World, is also performing incredibly well in the market. Thermalabs Organic Healthcare is the final sub-brand that the company has been working on lately. This will be an exclusive brand for organic healthcare products that are hand-made from herbs found in the mountains of Galilee, Israel.

According to Thermalabs marketing coordinator, Mr. Alex Howard, the company is partnering with dozens of distribution firm in Europe and other parts of the world. This will make sure that its products are widely available to the small demography that still doesn’t shop online.

For more information, please visit http://www.thermalabs.com/home

Contact Info:
Name: James Lawrence
Organization: Thermalabs

Video URL: https://www.youtube.com/watch?v=Qp2aAL9wvFU

Source: http://marketersmedia.com/thermalabs-brand-reviewing-its-global-market-strategy/123967

Release ID: 123967

IDGlobal Corporation Issues a Shareholder Update

BANNOCKBURN, IL / ACCESSWIRE / July 21, 2016 / IDGlobal Corp. (OTC: IDGC) is pleased to provide an update to its shareholders including the current portfolio, as well as the new direction the company is taking to create more shareholder value.

Our current portfolio holdings include various asset classes of such companies as: Jack Rockwell, Inc. (NV), NanoHydroceutical Solutions (NV), Inc. Phyhealth Corp. (PYHH)(DE), Physicians Healthcare Management Corp. (PHYH)(NV), Drone USA (DRUS)(DE), SaviCorp(NV), and EZ4Media, Inc.(NV) and AllSearch Semi, LLC (NV).

The company is announcing, in the near-term, a dividend to IDGC shareholders and setting a record date for common shares in Jack Rockwell, Inc, which has structured JRIP, LLC (NV – LLC) to hold its existing issued Patents. IDGC is assisting JRI Management to become a publicly traded company.

The company is announcing, in the near-term, a dividend to IDGC shareholders and setting a record date for common shares in NanoHydroceutical Solutions, Inc. IDGC is also assisting NANO Management in becoming a publicly traded company.

Phyhealth Corp. (PYHH) -1,000,000 common shares ownership and has engaged legal counsel in assisting in depositing these common shares.

Physicians Healthcare Management Corp. (PHYH) – has an assignment of approximately $365,532.34 in accounts receivable and IDGC is beginning the process with PHYH management to find an adequate target company and is assisting in becoming a publicly traded company.

EZ4Media, Inc. (“EZ4”), a Nevada Corporation, headquartered in Plano, Texas acquired all the technology, work-product and Intellectual Property assets from Brightscale, Inc. and currently holds these assets in its wholly owned subsidiary Allsearch Semi LLC. EZ4 is a fabless semiconductor company specializes in the design and sale of semiconductor chips while outsourcing the fabrication or “fab” of the chips to a specialized manufacturer called a semiconductor foundry. EZ4 also has a research and development team located at the Politehnica University of Bucharest, Romania. On July 5, 2016 the proposed acquisition of EZ4Media by IDGlobal Corp. Letter of Intent was signed by the majority shareholders of both IDGlobal Corp and EZ4Media.

Lastly, the company updated and posted to the IDGlobal Corp. website the Q1 2016 Financials, and will supply more details regarding status of corporate holdings, including DRUS and SaviCorp. in the Q2 2016 Financials and will post to OTC Markets in the near future.

Sebastien DuFort, current CEO stated, “We will remain focused on the dividend of some company holdings to existing sharesholders. FSG, Inc. will continue consulting services while in negotiations with an existing operating company with new management. We are diligently working with EZ4Media management in finalizing a definitive agreement.”

About IDGlobal Corporation

IDGlobal Corporation (IDGC) is a diversified holdings company with a focus on emerging and middle market investment opportunities in North America. IDGC seeks, through debt and equity investments, minority positions as well controlling interests in established companies and special situation start-ups.

Forward-Looking Statements

This press release contains statements which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of IDGlobal Corporation and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact:

Sebastien C. DuFort
847.582.9920 or 630.532.3625

SOURCE: IDGlobal Corporation

ReleaseID: 442649

Lexaria Engages Respected Consulting and Finance Firms

KELOWNA, BC / ACCESSWIRE / July 21, 2016 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company”) is pleased to announce it has entered into two agreements with highly respected New York based firms.

The first agreement is with PPMT Strategic Group, Inc, (“PPMT”) a strategic consulting group with widespread capabilities that include, Mergers & Acquisitions advisory services, Sales and Marketing, Industry Partnering, Compliance and Executive CFO services and much more. PPMT is expected to gain access on behalf of Lexaria to potential industry partners in the sectors where Lexaria’s technology holds immense promise: such as generic vitamins and supplements and pain medications, as well as other sectors.

PPMT offers a wide range of business advisory capabilities designed to augment the management functions of Microcap Companies and their Board of Directors. In entering this agreement Lexaria has significantly enhanced its Management breath of expertise in a cost effective manner. Lexaria expects PPMT to introduce the Lexaria Technology and Products to their network of business relationships that are mutually beneficial and lead toward much higher awareness and visibility for Lexaria’s products and technology.

“We are excited to work with the Lexaria team to accelerate the introduction of their technology to the market. We believe that Lexaria Technology has the potential to disrupt the nutraceutical and the OTC sectors,” said Wesley Ramjeet, CEO of PPMT Strategic Group.

The second agreement is with Terra Nova Capital Partners, Inc, a boutique investment and merchant banking firm with global reach. Established in 1999, the firm has led or participated in capital raises and/or financings of over $465 million since 2003, and is a FINRA registered broker-dealer. Terra Nova reaches a global network of over 28 countries and will be providing Lexaria with advice, support and expertise with its capital needs for the 12-month term of the engagement.

Terra Nova is a leading advisor to micro-cap public companies in private placements and other forms of company financing, and is part of the Global Alliance Partners network which has collectively completed over $33 billion in over 1,000 corporate transactions.

“We couldn’t be more pleased than to be working with such reputable and capable firms as Terra Nova and PPMT Group,” said Chris Bunka, CEO of Lexaria. “These new relationships will strengthen Lexaria in many ways and focus on immediate and achievable targets that will build our brands and our business.”

PPMT will receive 250,000 restricted common shares as initial payment under the agreement. PPMT will receive 250,000 warrants to purchase common shares each month until the end of the agreement, with a fixed floor price and otherwise subject to normal regulatory conditions.

The securities issued will be subject to a hold period for any resales into the USA under Rule 144 of six months and one day. All share and warrant issuances will be subject to normal regulatory approvals.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Lexaria

Lexaria Bioscience Corp. is a food sciences company focused on the delivery of active compounds that can behave as superfoods through its proprietary infusion technologies. Lexaria’s technology enables higher bioavailability rates for CBD; THC; NSAIDs; Nicotine and other molecules than is possible without lipophilic enhancement technology. This can allow for lower overall dosing requirements and/or higher effectiveness in active molecule delivery. Lexaria hopes to reduce other common but less healthy ingestion methods such as smoking as it embraces the benefits of public health. www.lexariaenergy.com

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Bioscience Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any license arrangements may be entered into with other companies or partners, that the Company’s technology will prove to be beneficial to third parties or to generate revenue for the Company. There is no assurance that the engagement of PPMT Strategic Group Inc. will result in higher visibility or awareness of the Company’s products or technology. Forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the engagement of consultants or participation in the hemp oil sector or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors or as a result of the engagement of consultants. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital despite the engagement of Terra Nova Capital Partners. There is no assurance that any planned corporate activity, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any patent application in the USA or any other nation or under any treaty will result in the award of an actual patent; nor that an award of any actual patent will protect against challenges from unknown third parties. There is no assurance that any definitive agreement will be reached to license the Company’s technology to any third party in return for compensation. There is no assurance that the Company’s competitive position, financial leverage, or likelihood of receiving additional patent allowances will be improved as a result of any potential future patent allowance by the USPTO. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.

The
CSE has not reviewed and does not accept responsibility for the adequacy or accuracy
of this release.

SOURCE: Lexaria Bioscience Corp.

ReleaseID: 442642

NGS Market To Witness Enhanced Penetration In Treatment Monitoring Of Chronic Diseases Till 2024: Grand View Research, Inc.

According to report published by Grand View Research, Inc. global next generation sequencing market revenue is anticipated to reach USD 14.0 billion by 2024, Growing adoption of next generation sequencing techniques for prognosis and treatment monitoring of different chronic diseases .

NGS Market To Witness Enhanced Penetration In Treatment Monitoring Of Chronic Diseases Till 2024: Grand View Research, Inc.

San Francisco, California, United States – July 21, 2016 /MarketersMedia/

The global next generation sequencing market will be worth $14.0 billion by 2024, according to report by Grand View Research, Inc. Growing adoption of next generation sequencing techniques for prognosis and treatment monitoring of different chronic diseases such as cancer and other pathogenic infections is one of the high impact rendering driver for progress in this industry.

Application of genome and exome sequencing in the field of cancer research for companion diagnostics and biomarker development are expected to contribute towards the growth of this market throughout the forecast period.

Moreover, anticipated exponential decrease in the prices of genome sequence determination coupled with the launch of novel platforms and whole genome sequencers by major market players is expected to have a significant positive impact on the market penetration of various NGS applications.

Access full research report: http://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market

Key findings

• Out of the different applications served by NGS technology, Oncological applications accounted for the dominant share owing to phase-resolved and unambiguous results obtained by using single assay systems, and analysis program. However, the use of HLA typing in gaining insights for organ rejection, organ matching, and immune disorders by understanding intricacies of less accessible genetic sequence structures is anticipated to provide scientists with new avenues for medical research over the forecast period.
• Depending on the approaches by which the number of base pairs can be determined in a given sequencing read cycle, the technologies can be segmented as targeted sequencing & resequencing, whole genome, and whole exome sequencing. Targeted resequencing dominated the market with a revenue share of over 70%owing to the benefits associated with implementation of the technique such as lower turnaround time and more manageable data sets.
• Amongst workflow steps involved, NGS data analysis encompasses the final phase of data storage and analysis of large amounts of sequenced data which is generated. This segment is expected to witness growth in demand in tandem to growth in demand for NGS through to 2024.
• Academic R&D usage of NGS accounted for the largest share with respect to market revenue by end uses and is anticipated to maintain its dominance owing to higher adoption of this technology and platforms in university projects related to molecular, genetic & proteomic biology, and drug discovery/development.
• North America dominated the market in 2015, generating over 46% of total revenue. Presence of the key participants operating in this region which are involved in development of novel algorithms and software in order to enhance data analysis is attributive for the large share of North America in industrial revenue. Demand for whole genome sequencing services for disease progression monitoring is also expected to drive industrial progress.
• Asia Pacific is estimated to witness the fastest growth over the forecast period owing to the expected routing of a considerable portion of whole genome sequencing requirements through a couple of the world’s largest sequencing facilities present in the region and potential presence of unmet demands by the research institutions with respect to sequence determination techniques and data analysis algorithms.
• This market is witnessing high level of competitive rivalry, consequently leading to constant endeavors carried out by the prominent players in order to maintain the position and share in the industry. These endeavors include launch of novel products, providing services and products in different economies across the globe, broadening of the product portfolio with respect to various application areas, and acquisition of the smaller entities in attempts to enhance product portfolio. For instance, Qiagen acquired solutions unit of Enzymatics in order to enhance the product portfolio with respect to reagents needed in preparatory steps.

Request for free sample of this research report: http://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market/request

Market Segments:

Outlook, by Application (Revenue, USD Million, 2013 – 2024)
• HLA Testing
• Prenatal Testing
• Oncology
• Idiopathic Diseases
• Infectious Diseases
Outlook, by Technology (Revenue, USD Million, 2013 – 2024)
• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Sequencing and Resequencing
Outlook, by Workflow (Revenue, USD Million, 2013 – 2024)
• NGS Pre-Sequencing
• NGS Sequencing
• NGS Data Analysis
o NGS Primary Data Analysis
o NGS Secondary Data Analysis
o NGS Tertiary Data Analysis
Outlook, by End-use (Revenue, USD Million, 2013 – 2024)
• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharma & Biotech Entities
• Other users
Regional Outlook (Revenue, USD Million, 2013 – 2024)
• North America
o U.S.
o Canada
• Europe
o Germany
o UK
• Asia Pacific
o China
o Japan
• Latin America
o Brazil
• MEA
o South Africa

Access press release of this research report: http://www.grandviewresearch.com/press-release/global-next-generation-sequencing-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

For more information, please visit http://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-market

Contact Info:
Name: Sherry James
Email: sales@grandviewresearch.com
Organization: Grand View Research, Inc.
Address: 28 2nd Street, Suite 3036, San Francisco, California, 94105
Phone: 1-415-349-0058

Source: http://marketersmedia.com/ngs-market-to-witness-enhanced-penetration-in-treatment-monitoring-of-chronic-diseases-till-2024-grand-view-research-inc/124501

Release ID: 124501

Sack Lunch Productions, Inc. $10 million in Sales Last 6 Months – Valuation

MIAMI, FL / ACCESSWIRE / July 21, 2016 / EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Sack Lunch Productions, Inc. (OTC Pink: SAKL).

View valuation discussions, recent news and other events concerning Sack Lunch Productions, Inc. (OTC Pink: SAKL) on EmergingGrowth.com:
http://emerginggrowth.com/?s=SAKL.

Sack Lunch Productions, Inc. (OTC Pink: SAKL), total sales were $10,015,813 across all subsidiaries, inclusive of corporate and franchised events in North America for the six months ended June 30, 2016.

Currently, the company has a market capitalization of about $9.8 million, which translates to a price-sales ratio of 0.9x. This is significantly lower than the industry’s 2.0-2.4x average, according to Morningstar data. If the company’s shares were to trade with a 2.0x price-sales ratio, it would translate to a $21.4 million market capitalization that’s about 120% higher than its current valuation – and the stock would still be on the low end of the range.

Sack Lunch Productions, Inc. (OTC Pink: SAKL), new to EmergingGrowth.com, operates in the action-oriented events entertainment industry.

Sack Lunch Productions, Inc. (OTC Pink: SAKL) has five main events:

  • Slide the City – 1,000-foot waterslide
  • Color Me Rad – color-based 5K race
  • The Dirty Dash – obstacle course and mud run
  • The Lantern Fest – nighttime event, featuring lighting and launching of spiritual lanterns
  • Trike Riot – adult-size tricycle race/ride

As of July 2016, Sack Lunch Productions, Inc. (OTC Pink: SAKL) is forecasting full year 2016 revenues of $17.2 million on net income of $1.2 million. For full year 2017, management sees total revenue of $18.3 million on net income of $2.7 million. The earnings growth is expected to be backed by continued international expansion, strategic acquisitions, and further organic growth of its events entertainment business in the United States.

View valuation discussions, recent news and other events concerning Sack Lunch Productions, Inc. (OTC Pink: SAKL) on EmergingGrowth.com:
http://emerginggrowth.com/?s=SAKL.

About
Sack Lunch Productions:

Sack Lunch Productions, Inc. (OTC PINK: SAKL) is an entertainment company that operates and franchises action oriented events in the U.S. and internationally. SAKL’s events include: Slide the City™ (1,000 foot long water slide for families and kids), Color Me Rad™ (5k color race), The Dirty Dash™ (mud and obstacle run), The Lantern Fest™ (nighttime party with lantern lighting and launch) and Trike Riot. Learn more about SAKL’s operations at www.sacklunchproductions.com, www.slidethecity.com, www.thelanternfest.com, www.thedirtydash.com, www.colormerad.com, www.trikeriot.com and www.green-endeavors.com.

SAKL strongly encourages the public to read the above information in conjunction with its reports filed at www.otcmarkets.com. The actual results that SAKL may achieve could differ materially from any forward-looking statements due to a number of risks and uncertainties, including but not limited to adverse weather conditions, equipment failure, state and local health code laws which may impact obtaining permits, low attendance and other risks associated with judgment calls made by various government officials. Investors should not invest more than they can afford to lose.

About EmergingGrowth.com

EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

Disclosure:

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks. This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. Full details about which can be found in our full disclosure, which can be found here, http://emerginggrowth.com/disclosure-7255. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

CONTACT:

Company: EmergingGrowth.com – http://www.EmergingGrowth.com
Contact Email: EmergingGrowth1@gmail.com

SOURCE: EmergingGrowth.com

ReleaseID: 442650

IFAN Financial, Inc. Expands Customer Base to Non-Governmental Organizations, Charities, International Remittance Market

PayX Platform Presented at Leadership Council to the Media for Social Impact Summit 2016; Platform Reduces Costs for Non-Profit, Remittance Sector

SAN DIEGO, CA / ACCESSWIRE / July 21, 2016 / IFAN Financial, Inc. (OTC PINK: IFAN), (“IFAN” or “the Company”), a designer, developer, and distributor of software to enable mobile payments, announced that it has begun a sales and marketing initiative to add Non-Governmental Organizations (NGOs), Charities and the International Remittance market to its global customer base. At the invitation of Edward Martin, a member of the Leadership Council, IFAN presented its PayX platform at the Media for Social Impact Summit 2016.

The Media For Social Impact Summit is an exclusive by invitation only event that unites representatives of leading media companies, advertising firms and creative agencies with high level United Nations representatives and communication experts to highlight the power of media to drive social change and strategize campaigns around pressing global issues.

Organized by the United Nations Office for Partnerships and PVBLIC Foundation, the summit showcases innovative social campaigns and movements through keynotes, interviews, case studies and roundtables and provides a unique opportunity for delegates to network and learn from the brightest minds in media and build lasting partnerships that further social progress.

Jason Aplin (EVP Sales & Marketing) met with Global Leaders in Design Agencies, Media, and Filmmakers at the Summit. He said, “The PayX Platform was presented and well received as a cost effective solution in facilitating the needs of those who are unbanked, the underbanked global diaspora, and those engaged in international remittance.”

He added, “The PayX Platform is seen as a mechanism for partnerships with NGOs and leaders of Sustainable Development Goals (SDG’s) that offer a method of generating additional revenue to further their causes. The PayX Platform eliminates many of the costly fees associated with donations and money movement for non-profits. There are countless charities involved in these areas. Currently, when they accept a donation via credit card, they have to give up a significant portion. We can offer the same services for far less, meaning that more of the donation gets to where the donor wants it spent.”

J. Christopher Mizer, President and CEO of IFAN Financial, “The world is rapidly moving towards cashless transactions and this is another arena where IFAN can help reduce costs, enhance security and deliver a user friendly experience all at the same time. IFAN is entering the preliminary stages to develop a long-term strategic relationship with the United Nations and its partnering organizations. McKinsey and Company estimates that 2.5 billion people are without banking services of any kind. Around 2.2 billion of them live in Africa, Asia, Latin America, and the Middle East – the very markets that are most likely to grow in the coming years. By making transactions easier, by bringing our services to those who need them, we can make a difference in their lives and boost their economies.”

About IFAN Financial, Inc.:

IFAN Financial, Inc., along with its wholly owned subsidiaries and joint ventures, design, develop, and distribute technology to enable and enhance mobile and traditional payments. The IFAN Platform consists of proximity based beacons, merchant processing, a mobile wallet, and prepaid card and debit card options. IFAN’s consumer facing entity, PayX, includes a portfolio of payment solutions through the mobile optimized platform capable of facilitating on-demand payments, auto-payments, split-funded payments, proximity marketing, and spending of platform funds through a linked card. IFAN and PayX provide businesses with the world’s first white label, mobile optimized platform that connects to any point of sale system and enables the next generation of marketing and payments with the capability to remit internationally. For more information, visit www.ifanfinancial.com.

Forward-Looking Statements:

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Although forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements, including but not limited to our ability to maintain our website and associated computer systems, our ability to generate sufficient market acceptance for our products and services, our ability to generate sufficient operating cash flow, and general economic conditions. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission from time to time which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one of more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Contact:

IFAN Financial, Inc.
Steve Scholl
Chief Financial Officer
3517 Camino del Rio South
Suite 407
San Diego, CA 92108
Direct: 858-277-9868
FAX: 619-923-2907
sscholl@ifanfinancial.com
www.ifanfinancial.com

SOURCE: IFAN Financial, Inc.

ReleaseID: 442645

The “Article and Blog Writing Wizard” Proudly Risks Defying Convention

Miles Internet Marketing has defied convention in the Article and Blog Writing market with the release of the Article and Blog Writing Wizard service. Further information can be found at on the informative website http://MilesInternetMarketing.com.

The “Article and Blog Writing Wizard” Proudly Risks Defying Convention

Wrentham, MA, USA – July 21, 2016 /PressCable/

Earlier today, Miles Internet Marketing finally announced the release of the “Article and Blog Writing Wizard”. It’s new and is the answer for everyone who wants to write a blog but never gets to it. This service has been in development since since January of 2016. The main aim is to eliminate the burden of trying to write articles and blogs. The ease of having them professionally written will relieve a lot of stress…. but it does so, with a difference.

David Miles, Owner and Founder at Miles Internet Marketing, says: “We wanted to try something new with the “Article and Blog Writing Wizard”. Anyone familiar with the article and blog Writing market will probably have noticed how most of our competitiors currently seem to offer a more limited option and at a much higher price point. This is a problem because it’s hard to find a good source of writers that can create articles on virtually any market niche or topic”.

So as a welcome breath of fresh air, “Article and Blog Writing Wizard” will instead be capable of writing fresh quality articles on almost any topic. Miles Internet Marketing chose to make this move because this was a problem for the company and many curent clients. It was clear there was a need in the marketplace.

David Miles also said “We want to give our clients a one stop option to meet a need that will reduce the stress of fretting over trying to get the next blog ready to post. With “Article and Blog Writing Wizard”, they have a fresh new possibility and we can even post the articles if that is needed. We want our clients to feel comfortable knowing they will receive a high quality article and relaxed that the blogs will be ready on time when using “Article and Blog Writing Wizard”. Trying something new is always a risk, but it’s a risk we believe is worth taking”.

Miles Internet Marketing has been in business since 2009. Beginning on day one the company has always strived to create a level playing field so that small and mid sized businesses could compete with the big budget guys..

This isn’t the first time Miles Internet Marketing has defied convention either. Miles Internet Marketing is always trying to blaze new trails with services that are either very unique or extemely cost competitive. The business has created a stir by being able to offer services that go beyond cutting edge techniques.

“Article and Blog Writing Wizard” has been available sine the beginning of July 2016.

For further information about Miles Internet Marketing and all of the services offered go to http://MilesInternetMarketing.com

For more information, please visit http://MilesInternetMarketing.com

Contact Info:
Name: David Miles
Organization: Miles Internet Marketing
Address: 215 Bennett Street, Wrentham, MA 02093
Phone: 508-404-4389

Release ID: 124019

Industrial Enzymes Market To Witness Enhanced Usage In Detergent And As Ingredient In Food Processing Industries Till 2024

According to report published by Grand View Research, Inc. global industrial enzymes market will be worth $9.63 billion by 2024, market is expected to witness significant growth owing to increasing substitution of chemicals with industrial enzymes particularly in food & beverage and nutraceutical applications.

Industrial Enzymes Market To Witness Enhanced Usage In Detergent And As Ingredient In Food Processing Industries Till 2024

San Francisco, California, United States – July 21, 2016 /MarketersMedia/

The global industrial enzymes market is expected to reach USD 9.63 billion by 2024, according to a new report by Grand View Research, Inc. The market is expected to witness significant growth owing to increasing substitution of chemicals with industrial enzymes particularly in food & beverage and nutraceutical applications.

Growing applications of industrial enzymes for use in detergents and as ingredients in food processing industry is expected to fuel the demand. Proteases are extensively used in the detergent industry owing to its superior stain removal properties. However, the demand in the detergent application is expected to witness sluggish growth owing to market saturation.

Growing use of protease in bakery products is expected to drive market growth. Furthermore, increasing application scope of the product in nutraceutical industry as a digestive enzyme is expected to drive demand.

Technological advancements in the field of industrial enzymes have led to the use of the product as cleaning agents. The increasing use of enzymes or waste water treatment is also expected to drive the demand over the forecast period.

Neozymes, DSM, and Danisco dominated the global industrial enzymes market in 2015 with the industry being characterized by forward integration by manufacturers to distribution and end-use. Manufacturers such as DuPont and DSM manufacture industrial enzymes for specialized applications. The global industrial enzymes market is dominated by North America due to the presence of a large number of manufacturers in the U.S. and Canada.

Access full research report: http://www.grandviewresearch.com/industry-analysis/industrial-enzymes-market

Key findings

• Industrial enzymes demand for lipases is expected to witness substantial growth, growing at over 8.0% from 2016 to 2024. Increasing demand for the product in food & beverage and textile industry is expected to augment growth over the forecast period.
• The feed additive enzymes are expected to be the fastest growing product segment, growing at over CAGR 9.0% from 2016 to 2024. The increasing use of enzymes as a protein source in animal feed is to improve performance in livestock which in turn is anticipated to drive demand over the projected period.
• Asia Pacific is expected to witness substantial growth, growing at a CAGR of over 10.0% from 2016 to 2024. Robust expansion in food processing industries particularly in Asia Pacific is expected to augment growth. Furthermore, the supportive regulations promoting the expansion of manufacturing industries is expected to have a positive impact on market growth.
• Europe accounted for over 29.0% of the market share in 2015 and is expected to witness significant growth owing to rising demand in pharmaceutical and textile industry. Stringent regulations prohibiting the use of toxic chemicals and catalysts in various applications is expected to positively impact market over the next eight years.
• Key players in the industry include BASF SE, Koninklijke DSM N.V, Novozymes A/S., Associated British Foods PLC E. I. Du Pont De Nemours and Company Adisseo France SaS, Dyadic International Incorporated CHR, Codexis Incorporated. Hansen Holding A/S, and Amano Enzyme Incorporated.

Request for free sample of this research report: http://www.grandviewresearch.com/industry-analysis/industrial-enzymes-market/request

Market Segments:

Product Outlook (Revenue, USD Million, 2013 – 2024)
• Carbohydrase
• Proteases
• Lipases
• Polymerases & nucleases
• Others
Application Outlook (Revenue, USD Million, 2013 – 2024)
• Technical
• Feed additive
• Food processing
End-use Outlook (Revenue, USD Million, 2013 – 2024)
• Food & beverage
• Detergents
• Animal feed
• Textile
• Paper & pulp
• Nutraceutical
• Personal care & cosmetics
• Wastewater
Regional Outlook (Revenue, USD Million, 2013 – 2024)
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Asia Pacific
• China
• India
• Japan
• Latin America
• Brazil
• Middle East & Africa
• South Africa

Access press release of this research report: http://www.grandviewresearch.com/press-release/global-industrial-enzymes-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

For more information, please visit http://www.grandviewresearch.com/industry-analysis/industrial-enzymes-market

Contact Info:
Name: Sherry James
Email: sales@grandviewresearch.com
Organization: Grand View Research, Inc.
Address: 28 2nd Street, Suite 3036, San Francisco, California, 94105
Phone: 1-415-349-0058

Source: http://marketersmedia.com/industrial-enzymes-market-to-witness-enhanced-usage-in-detergent-and-as-ingredient-in-food-processing-industries-till-2024/124495

Release ID: 124495

Emulsion Polymer Market To Gain From Enhanced Usage In Paints, Coating And Adhesives Till 2024: Grand View Research, Inc.

According to report published by Grand View Research, Inc. global emulsion polymer market size will be worth $56.86 million by 2024, demand expected to reach 21.88 million tons, growing at a CAGR of 5.7% from 2016 to 2024.

Emulsion Polymer Market To Gain From Enhanced Usage In Paints, Coating And Adhesives Till 2024: Grand View Research, Inc.

San Francisco, California, United States – July 21, 2016 /MarketersMedia/

The global emulsion polymer market is expected to reach USD 56.86 million by 2024, according to a new report by Grand View Research, Inc. Acrylic use for superabsorbent polymers and personal care products is increasing on account of their quick drying ability and water resistance characteristics. Such favorable characteristics are anticipated to augment overall industry demand.

Increasing construction spending, particularly in Asia Pacific and the Middle East, has prompted the demand for paints & coatings in the recent past. The growth of paints & coatings industry has had a direct impact on emulsion polymer demand. Stringent environmental regulations to control noxious chemical emissions coupled with increasing preference for greener products are expected to limit synthetic based demand and augment bio-based and water based product demand. Volatile prices of key raw materials are expected to remain a key challenge for market participants over the forecast period.

Acrylics was the leading product segment and accounted for 39.3% of total market volume in 2015. High demand for diapers & training pants and personal care particularly in the emerging markets of Asia Pacific is expected to drive this segment over the forecast period. It is also expected to witness the highest growth of 6.0% from 2016 to 2024.

Access full research report: http://www.grandviewresearch.com/industry-analysis/emulsion-polymer-market

Key findings

• The global emulsion polymer market demand was 13.36 million tons in 2015 and is expected to reach 21.88 million tons by 2024, growing at a CAGR of 5.7% from 2016 to 2024
• Paints& coatings emerged as the leading application segment with demand share exceeding 35% in 2015. Increasing construction activities in China, India, South Korea and the Middle East coupled with a positive outlook on the global automotive industry is expected to drive this segment over the forecast period.
• Asia Pacific was the leading regional market with demand share estimated 40% in 2015. Rapid urban construction has increased the paint consumption which in turn is expected to fuel the global market. Asia Pacific is also expected to witness the fastest growth of 7.2% from 2016 to 2024.
• Key players operating in the global emulsion polymer market include Nuplex industry, Synthomer, STI polymer, Wacker Chemie AG, BASF, Omnova Solutions, Styron, Clariant International Limited, and DIC Corporation. Product innovation coupled with expansion strategies are expected to be adopted by the mid-sized manufacturers to increase their global presence.

Request for free sample of this research report: http://www.grandviewresearch.com/industry-analysis/emulsion-polymer-market/request

Market Segments:

Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2016 – 2024)
• Acrylics
• Styrene-Butadiene Latex
• Vinyl Acetate Polymers
• Others
Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2016 – 2024)
• Paints and Coating
• Paper and Paperboard coating
• Adhesives
• Others
Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2016 – 2024)
• North America
• U.S
• Mexico
• Europe
• European Union (EU)
• Russia
• Turkey
• Asia Pacific
• China
• India
• Japan
• South Korea
• Central & South America
• Brazil
• Middle East and Africa

Access press release of this research report: http://www.grandviewresearch.com/press-release/emulsion-polymer-market-report

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

For more information, please visit http://www.grandviewresearch.com/industry-analysis/emulsion-polymer-market

Contact Info:
Name: Sherry James
Email: sales@grandviewresearch.com
Organization: Grand View Research, Inc.
Address: 28 2nd Street, Suite 3036, San Francisco, California, 94105
Phone: 1-415-349-0058

Source: http://marketersmedia.com/emulsion-polymer-market-to-gain-from-enhanced-usage-in-paints-coating-and-adhesives-till-2024-grand-view-research-inc/124497

Release ID: 124497